Ochre Bio CEO Jack O’Meara steps down, outlines plans for next startup

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Atropos Health raises $33M to arm doctors and pharma companies with evidence

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) With $33 million in fresh funding, Atropos

May 24, 2024

Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Merger 04-Nov-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

November 5, 2024

Youth and midlife diet quality linked to better brain health in later years

Eating a high-quality diet in youth and middle age could help keep your brain functioning well in your senior years, according to new preliminary findings

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.